Skip to main content

Part of UT Health San Antonio

Profiles - UT Health San AntonioProfiles - UT Health Science Center San Antonio

Part of UT Health San Antonio

Menu
  • Home

You are here

  • Profiles Home
  • Faculty Directory
  • Stanton McHardy
Stanton McHardy, PhD

Contact

210-458-8676

stanton.mchardy@utsa.edu

Programs

  • Ph.D. in Integrated Biomedical Sciences
  • Biochemical Mechanisms in Medicine
  • Molecular Immunology & Microbiology
  • Physiology and Pharmacology

Departments & Divisions

  • Department of Biochemistry & Structural Biology

Stanton McHardy, PhD

Adjuct Associate Professor

Chemistry

UTSA

Dr. McHardy’s lab and the CIDD are focused on medicinal chemistry research in the design, synthesis and development of small molecule compounds across multiple therapeutic disease areas. Currently funded programs are focused on the development of novel small molecules for breast, ovarian and brain cancers, metabolic diseases, Schistosomiasis, biofilm inhibition and dengue virus. The lab also focuses on the development of new synthetic methodologies for the synthesis of drug-like compounds and natural products.

  • Publications

      • Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer”, Bin Yuan, Long Cheng, Qinong Ye, Kshama Gupta, Huai-Chin Chiang, Yanfen Hu, Rong Li, Harshita B. Gupta, Kate Lathrop, Richard Elledge, Tyler J. Curiel, Gangadhara R. Sareddy, Ratna Vadlamudi, Degeng Wang, Pei Wang and Stanton F. McHardy, Oncotarget, 2016, Ahead of Print.
      • “Targeting Candida albicans filamentation for antifungal drug development”, Taissa Vila, Jesus A Romo, Stephen P. Saville, Jose L. Lopez-Ribot, Christopher G. Pierce and Stanton F. McHardy, Virulence, 2016, 1-9.
      • “Molecular dynamics study of human carbonic anhydrase II in complex with Zn2+ and acetazolamide on the basis of all-atom force field simulations”, Thierry O. Wambo, Liao Y. Chen, Stanton F. McHardy and Andrew T. Tsin, Biophysical Chemistry, 2016, 214-215, 54-60.
      • “A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance”, Christopher G Pierce, Ashok K Chaturvedi, Anna L Lazzell, Alexander T Powell, Stephen P Saville, Stanton F McHardy and Jose L Lopez-Ribot. NPJ Biofilms and Microbiomes, 2015, 15012.
      • “Design, Synthesis, and Characterization of Novel, Nonquaternary Reactivators of GF-Inhibited Human Acetylcholinesterase”, Stanton F. McHardy, Jonathan A Bohmann, Michael R Corbett, Bismarck Campos, Michael W Tidwell, Paul M Thompson, Chris J Bemben, Tony A Menchaca, Tony E Reeves, William R Cantrell, Jr, William E Bauta, Ambrosio Lopez, Donald M Maxwell, Karen M Brecht, Richard E Sweeney, John McDonough, Bioorganic & Medicinal Chemistry Letters, 2014, 24, 1711-1714.
map image

UT Health San Antonio

7703 Floyd Curl Drive
San Antonio, TX 78229

210-567-7000

We make lives better ©

We're a part of UT Health San Antonio, provider of comprehensive health,  dental, &  cancer care,  advanced academics,  and  life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.